Search all trials

Find therapies in clinical trials near you – page 24

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Metastatic malignant melanoma

Not recruiting

Registered drugNo placebo

Study of IO102-IO103 and Pembrolizumab for Patients with Advanced Melanoma

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Io102 Hydrochloride

Contact Research Centre

Plasma cell myeloma refractory

Not recruiting

Registered drugNo placebo

Study on Isatuximab, Carfilzomib, and Dexamethasone for Adults with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Carfilzomib

Contact Research Centre

Immune thrombocytopenia

Not recruiting

InvestigationalNo placebo

Long-term Study on the Safety and Efficacy of Efgartigimod in Adults with Primary Immune Thrombocytopenia

InvestigationalNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Efgartigimod Alfa

Contact Research Centre

Chronic lymphocytic leukaemia

Not recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of Epcoritamab, Venetoclax, and Lenalidomide for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Cyclophosphamide

Contact Research Centre

Plasma cell myeloma recurrent

Not recruiting

Registered drugNo placebo

Study Comparing Subcutaneous and Intravenous Isatuximab with Pomalidomide and Dexamethasone for Adults with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo

Czechia

Participants:65+ years
Substances:Dexamethasone

Contact Research Centre

Neoplasm malignant+1

Not recruiting

Registered drugNo placebo

Study of AZD5305 Alone and with Other Cancer Drugs for Patients with Advanced Solid Tumors

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Camizestrant

Contact Research Centre

Pancreatic carcinoma metastatic

Not recruiting

Registered drugNo placebo

Study on TTX-030, Budigalimab, and Chemotherapy for Untreated Metastatic Pancreatic Cancer Patients

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Budigalimab

Contact Research Centre

Gastrointestinal melanoma+7

Not recruiting

Registered drug

Study of Encorafenib, Binimetinib, and Pembrolizumab for Patients with Advanced Melanoma with BRAF V600E/K Mutation

Registered drug

Czechia

Participants:18–64 years · 65+ years
Substances:Binimetinib

Contact Research Centre

B-cell small lymphocytic lymphoma

Not recruiting

Registered drugNo placebo

Study Comparing Zanubrutinib with Bendamustine and Rituximab for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Rituximab

Contact Research Centre

Myelodysplastic syndrome

Not recruiting

Registered drug

Study of Tamibarotene and Azacitidine Treatment in Newly Diagnosed Adults with RARA-positive Higher-risk Myelodysplastic Syndrome (MDS)

Registered drug

Czechia

Participants:18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Prostate cancer metastatic

Not recruiting

Registered drug

Study of talazoparib and enzalutamide combination in men with DDR gene mutated metastatic castration-sensitive prostate cancer

Registered drug

Czechia

Participants:18–64 years · 65+ years
Substances:Enzalutamide

Contact Research Centre

Breast cancer+1

Not recruiting

Registered drugNo placebo

Study of PF-07220060 and PF-07104091 with Endocrine Therapy for Patients with Advanced HR-positive HER2-negative Breast Cancer

Registered drugNo placebo

Czechia

Participants:18–64 years · 65+ years
Substances:Fulvestrant

Contact Research Centre

Find therapies in clinical trials near you – page 24

342 trials match your criteria

Metastatic malignant melanoma

Study of IO102-IO103 and Pembrolizumab for Patients with Advanced Melanoma

Plasma cell myeloma refractory

Study on Isatuximab, Carfilzomib, and Dexamethasone for Adults with Relapsed or Refractory Multiple Myeloma

Immune thrombocytopenia

Long-term Study on the Safety and Efficacy of Efgartigimod in Adults with Primary Immune Thrombocytopenia

Chronic lymphocytic leukaemia

Study on the Safety and Effectiveness of Epcoritamab, Venetoclax, and Lenalidomide for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome

Plasma cell myeloma recurrent

Study Comparing Subcutaneous and Intravenous Isatuximab with Pomalidomide and Dexamethasone for Adults with Relapsed or Refractory Multiple Myeloma

Neoplasm malignant+1

Study of AZD5305 Alone and with Other Cancer Drugs for Patients with Advanced Solid Tumors

Pancreatic carcinoma metastatic

Study on TTX-030, Budigalimab, and Chemotherapy for Untreated Metastatic Pancreatic Cancer Patients

Gastrointestinal melanoma+7

Study of Encorafenib, Binimetinib, and Pembrolizumab for Patients with Advanced Melanoma with BRAF V600E/K Mutation

B-cell small lymphocytic lymphoma

Study Comparing Zanubrutinib with Bendamustine and Rituximab for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Myelodysplastic syndrome

Study of Tamibarotene and Azacitidine Treatment in Newly Diagnosed Adults with RARA-positive Higher-risk Myelodysplastic Syndrome (MDS)

Prostate cancer metastatic

Study of talazoparib and enzalutamide combination in men with DDR gene mutated metastatic castration-sensitive prostate cancer

Breast cancer+1

Study of PF-07220060 and PF-07104091 with Endocrine Therapy for Patients with Advanced HR-positive HER2-negative Breast Cancer

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.